Uncategorized Archives - Page 11 of 14 - IPHA
September 12, 2018

New President at IPHA

Aidan Lynch, Vice President and General Manager of GSK (Ireland) Limited, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA). In this position, […]
August 10, 2018

New Report Backs Biopharma Innovation as Enabler for New Treatments, Jobs and Investments, says IPHA

Protecting Ireland’s innovation policy environment is key to developing new medicines for patients, and to attracting fresh investments in pharmaceutical manufacturing and research, according to a […]
August 9, 2018

NEW IPHA DATA SHOWS IRISH PATIENTS DENIED ACCESS TO VITAL CANCER MEDICINES

Seven new cancer medicines available in 12 EU countries – but not yet in Ireland Persistent delays approving medicines at odds with Government’s cancer outcomes targets […]
July 2, 2018

Biopharma Industry’s Latest Price Drops Save €15m on Government’s Medicines Bill, says IPHA

Agreement with Government delivers more savings than forecast – but approvals process for medicines remains slow and inefficient Price reductions take effect for 750 packs of […]
June 22, 2018

IPHA Urges Progress on Access to Medicines as Ireland Signs Up to BeNeLuxA

As Ireland signed up today [Friday] to the BeNeLuxA Initiative on pricing and supply of innovative medicines, the Irish Pharmaceutical Healthcare Association (IPHA) has said the […]
May 28, 2018

Focus must remain on biopharma innovation as European Commission proposes new IP laws, says IPHA

The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research-based pharmaceutical industry in Ireland, has said a continued focus on innovation is key to unlocking the […]
April 23, 2018

Medicines Availability Bulletin Ireland and Europe

NEW IPHA RESEARCH SHOWS THAT IRELAND CONTINUES TO LAG EUROPE  Ireland lags western European countries in availability of new medicines Nine medicines in the Irish reimbursement […]
April 19, 2018

IPHA appoints Director of Communications and Advocacy

The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research-based pharmaceutical industry in Ireland, has announced the appointment of Mr Bernard Mallee to a new post […]
March 6, 2018

Oireachtas Health Committee report on Orphan Drugs welcomed by the pharmaceutical industry

The Irish Pharmaceutical Healthcare Association (IPHA), which represents 47 research based pharmaceutical companies in Ireland has welcomed the publication of a report on Evaluating Orphan Drugs […]